In connection with earlier intimation dated May 30, 2022 regarding the Outcome of the Board Meeting for approval of the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2022, and in accordance with Regulation 23 of Listing Regulations, Fermenta Biotech has informed that it enclosed the disclosure of Related Party Transactions for the half year ended March 31, 2022. This information will also be made available at https://www.fermentabiotech.com/investor_relations.php
The above information is a part of company’s filings submitted to BSE.
